Julien Fahed

Statistics

Publications

Citations

279

H-Index

Active since

2016

Affiliations

University of Massachusetts Chan Medical School(Current)

Julien Fahed is an author at University of Massachusetts Chan Medical School specializing in gastroenterology, inflammatory bowel disease, and pharmacy.

Publications per year

2016–2024

Publications

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Julien Fahed · The Lancet · 2024 · 102 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +11

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Smoking Cessation in a Chronic Pancreatitis Population

Samuel Han, Joan Kheder, Lisa Bocelli et al. · Pancreas · 2016 · 45 citations · Full text

Public Health, Health Behavior, Functional Decline +13

<i>Clostridium difficile</i> in Inflammatory Bowel Disease: A Retrospective Study

William Gillespie, Neil B. Marya, Julien Fahed et al. · Gastroenterology Research and Practice · 2017 · 25 citations · Full text

Medicine, Immunology, Infectious Diseases +15

Suspected Blood Indicator to Identify Active Gastrointestinal Bleeding: A Prospective Validation

Samuel Han, Julien Fahed, David R. Cave · Gastroenterology Research · 2018 · 24 citations · Full text

Medicine, Health Informatics, Internal Medicine +16

1–5 of 5